Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Effect of nadolol in treatment of induced ocular hypertension in rabbits

Breadcrumb

  • Home
  • Effect of nadolol in treatment of induced ocular hypertension in rabbits

Baha'a A. Abdul-Hussein 1, *, Hassanen A. Radi 2 and Sara Majeed Kareem 3

1 Department of Pharmacology, College of Veterinary Medicine, University of Al - Qadissiya, Al-Qadissiya, Iraq.
2 Department of ophthalmology, Al-Diwaniya Teaching Hospital. Al- Qadissiya, Iraq.
3 Department of Gynecology, Maternity and children hospital in AL- Diwaniya. Al-Qadissiya, Iraq.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 17(03), 124–130.
Article DOI: 10.30574/wjbphs.2024.17.3.0122
DOI url: https://doi.org/10.30574/wjbphs.2024.17.3.0122

Received on 29 January 2024; revised on 05 March 2024; accepted on 08 March 2024

In glaucoma, as optic neuropathy gradually proceeds unnoticed by the patient, early detection and treatment is of paramount importance in arresting or controlling the progress of damage.
To explore effects of topical nadolol on intraocular pressure (IOP) ocular hypertensive eyes of rabbits.
A group of 36 males of the rabbits were included in this study. Induction of ocular hypertension was achieved by injection of hydroxy propyl methylcellulose in the anterior chamber of rabbits right eye. The present study was designed to evaluate the possible beneficial therapeutic effect. The included rabbits were divided into distilled water group, timolol (0.25% and 0.5%) groups, and nadolol (0.25% and 0.5%). Each of drug eye drops (including distilled water) were instilled into right eyes 3 times/day for 10 days therapeutically. The rabbits had been examined for the IOP, pupil diameter, light reflex, corneal reflex, and conjunctival redness prior to instillation of drugs and along the trial period.
Results: Ocular hypotensive effects of nadolol (0.25%) and (0.5%) eye drops were more efficient than that of distilled water (P<0.01). Furthermore, nadolol eye drop was more efficient than timolol eye drop (0.01>P>0.05) in its ocular hypotensive effect in both concentrations along the trial period.
In both parts of the present study and regarding each of mean pupil diameter, light reflex, corneal reflex and conjunctival redness, nadolol (0.25% or 0.5%) eye drops had no significant adverse effect (P > 0.05).
Conclusions: Nadolol eye drops instilled 3 times / day had an obvious beneficial, safe, and tolerable therapeutic ocular hypotensive effects on hydroxy propyl methyl cellulose - induced ocular hypertension in rabbits.

Nadolol; Timolol; Ocular hypertension; Eye drops

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0122.pdf

Preview Article PDF

Baha'a A. Abdul-Hussein, Hassanen A. Radi and Sara Majeed Kareem. Effect of nadolol in treatment of induced ocular hypertension in rabbits. World Journal of Biology Pharmacy and Health Sciences, 2024, 17(03), 124–130. Article DOI: https://doi.org/10.30574/wjbphs.2024.17.3.0122

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution